Immuno-Oncology Clinical Network

🎟️Places are filling quickly for our next Case Conundrums Study Day in Bristol on March 27th 2026! Book now to avoid disapointment! 🎓🧬 🔗ticketsource.co.uk/immuno-oncolog…

🚨New Immunobuddies Episode out now! 🎧 Episode 183: RS3PE — A WiFi password from the 90’s or an actual toxicity? (Part 3) We’re back with the third instalment of our RS3PE mini-series — and this time we’re bringing it to life with a real clinical case. In this episode we: 🔍 Walk through the patient presentation 🧪 Explore the investigations that were carried out 🖥️ Unpick the imaging and diagnostic clues 🧠 Show how it all led to an RS3PE diagnosis Tune in to hear how the case unfolded and what it means for recognising RS3PE in practice. 🎧 Listen now wherever you get your podcasts. buzzsprout.com/2128662/episod… #ImmunoBuddies #RS3PE #Immunotherapy #irAEs #CaseStudy #Oncology #Rheumatology #Podcast @RickyFrazer1 @AOlssonBrown @IOClinicalNet @immunobuddies @UKAOSociety @UKONSmember @BOPACommittee @oncodaily @OncoDailyIO @onctrainees @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT @myESMO @ASCO

🚨Join us on Tuesday evening: 🙌Join the Immuno-Oncology Clinical Network (IOCN) for an exclusive Spotlight Webinar with Professor Monty Pal, an internationally recognised expert in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. This session will explore strategies to optimise immunotherapy outcomes and share insights from cutting-edge clinical practice. 🎟️ Free to attend – registration required 📷 Register here: ticketsource.co.uk/immuno-oncolog… @montypal @AOlssonBrown @RickyFrazer1 @cityofhope @cityofhopeoc @immunobuddies @UKONSmember @UKAOSociety @BOPACommittee #IOCN #ImmunoOncology #Immunotherapy #CancerCare #Webinar #OncologyEducation

🎧 New Podcast Episode Out Now! 🚨The Immunobuddies – Episode 180 Impact of Diet on Immunotherapy & Practical Approaches (Final Part) In the final episode of this diet and immunotherapy series, we’re joined by the wonderful Raiatea Van-Reenen, Immunotherapy Dietician at University Hospitals Derby, to bring together the evidence, clinical insight, and real-world practical advice. 🍽️ Topics include: • Translating nutrition evidence into everyday immunotherapy care • Practical, patient-centred dietary strategies • The important role of dieticians within the immunotherapy MDT • Supporting patients holistically alongside treatment A must-listen for clinicians, nurses, AHPs, and anyone supporting patients on immunotherapy. 👉 Listen now: buzzsprout.com/2128662/episod… @AOlssonBrown @RickyFrazer1 @UHDBTrust @IOClinicalNet @immunobuddies @myESMO @ASCO @BOPACommittee @UKONSmember @UKAOSociety @oncodaily @OncoDailyIO @onctrainees @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT #Immunotherapy #CancerCare #Oncology #DietAndImmunotherapy #MDTWorking #IOCN #ImmunobuddiesPodcast

🌍 World Cancer Day Today, we want to say a heartfelt thank you to everyone across the Immuno-Oncology Clinical Network (IOCN). We’re incredibly proud to share that IOCN has just reached 1,000 members — a huge milestone that reflects the strength, commitment, and shared purpose of this growing community. 🎉 1,000 voices, one shared goal: improving immuno-oncology care and outcomes for patients. Every day, you support patients through increasingly complex immunotherapy pathways — managing toxicity, sharing expertise, improving services, and driving forward best practice. Your collaboration and generosity in sharing knowledge are what make the IOCN such a trusted and valuable network across the UK. This World Cancer Day reminds us that cancer care is about people, not just disease. Thank you for the work you do — often behind the scenes — and for being part of the IOCN as we continue to learn, grow, and improve care together. 💚🧡💙💛🩷 #WORLDCANCERDAY #IOCN #ImmunoOncology #CancerCare #StrongerTogether #UNITEDBYUNIQUE #Community @AOlssonBrown @RickyFrazer1 @immunobuddies

🚨 IOCN Spotlight Webinar 🚨 📅 Tuesday 10th February ⏰ 7:00pm (UK time - GMT) 💻 Live webinar Optimising Immunotherapy Outcomes with Professor Monty Pal (City of Hope, California) Join the Immuno-Oncology Clinical Network (IOCN) for an exclusive Spotlight Webinar with Professor Monty Pal, an internationally recognised expert in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. This session will explore strategies to optimise immunotherapy outcomes and share insights from cutting-edge clinical practice. 🎟️ Free to attend – registration required 👉 Register here: ticketsource.co.uk/immuno-oncolog… @montypal @AOlssonBrown @RickyFrazer1 @cityofhope @cityofhopeoc @immunobuddies @UKONSmember @UKAOSociety @BOPACommittee #IOCN #ImmunoOncology #Immunotherapy #CancerCare #Webinar #OncologyEducation

📚 Case Conundrums Study Day! Join the IOCN for our next in-person learning event! 🗓 Friday 27 March 2026 📍 Bristol ⏰ 9:30am – 5:00pm 🙌A full day of interactive case discussions, shared learning, and expert insight. With a brand-new agenda and fresh cases, even if you’ve joined us before, there’s plenty more to explore. Register Today: tinyurl.com/5bs8sve6 🗣️"Thought last year would be difficult to beat but this was superb. Fantastic educational event with informality." (Birmingham, October 2025) @PeninsulaCancer @CCAlliance @hncalliance @CanAlliance_SYB @SurreySussexCA @EOE_cancer @WYHCanAlliance @GM_Cancer @GICAlliance @nclcancer @NHS_WCA @NorthernCancer @NHS_WMCA @cancer_east @HNYCancer @NHS_SELCA @GMCancerPPIE @CancerNel @nhskmca @CMCaAlliance @WalesCancer @LSC_CA_ALLIANCE @ThamesV_Cancer @OCCA_Cancer @SWAGCaAlliance @AOlssonBrown @RickyFrazer1 @alicetew @BOPACommittee @UKONSmember @UKAOSociety @OncEd @OncologyNT @ACPUK @immunooncnews @OncoDailyIO @oncodaily @OncoDailyGI @OncoViews @myESMO @RCPhysicians

🎧 NEW PODCAST EPISODE 🚨 Episode 178 is now live on the Immunobuddies Podcast 🎙️ In Part 2 of our series on the Impact of Diet on Immunotherapy, we continue the conversation with Immunotherapy Dietician Raiatea Van-Reenen (University Hospital Derby), focusing on practical, real-world approaches. This episode explores: 🥗How diet can support patients during treatment, including approaches to managing common side effects 🦠Supporting gut health, and translating emerging evidence into realistic, patient-centred advice. The discussion highlights the importance of personalised nutrition support and multidisciplinary working in immunotherapy care. 🎙️ Listen now to Part 2 — and catch up on Part 1 if you missed it. tinyurl.com/39cbzv9t 👉 Parts 3 & 4 coming soon! @AOlssonBrown @RickyFrazer1 @UHDBTrust @IOClinicalNet @immunobuddies @myESMO @ASCO @BOPACommittee @UKONSmember @UKAOSociety @oncodaily @OncoDailyIO @onctrainees @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT #Immunobuddies #Immunotherapy #OncologyNutrition #DietAndCancer #Microbiome #AlliedHealthProfessionals #PodcastSeries

🎧 NEW PODCAST EPISODE – PART 1 OF 4 We’re kicking off a brand-new 4-part series on the Impact of Diet on Immunotherapy in the latest episode of the Immunobuddies Podcast. In Part 1, we’re joined by Immunotherapy Dietician Raiatea Van-Reenen (University Hospital Derby) to explore: 🥗 How diet interacts with the immune system 🦠 The role of the gut microbiome in immunotherapy 🧠 What the evidence really says (and what it doesn’t) 🩺 Practical, patient-centred dietary approaches during treatment This series will break down nutrition, immunotherapy, and real-world clinical practice in a clear and practical way for healthcare professionals and patients alike. 🎙️ Listen now and stay tuned for Parts 2–4 coming soon. tinyurl.com/y6cszkcb @AOlssonBrown @RickyFrazer1 @UHDBTrust @IOClinicalNet @immunobuddies @myESMO @ASCO @BOPACommittee @UKONSmember @UKAOSociety @oncodaily @OncoDailyIO @onctrainees @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT #Immunobuddies #Immunotherapy #Dieticians #OncologyNutrition #Microbiome #CancerCare #AlliedHealthProfessionals #PodcastSeries

🎧 New Immunobuddies mini-series now live! 🚨 Missed an episode? Now’s the perfect time to catch up. Episodes 175 & 176 of Immunobuddies form a two-part mini-series on: 👉 Immunotherapy in older patients 🗣️We are joined by Dr Nicolo Battisti and Dr Mark Baxter with thoughtful discussion and real-world perspectives, we unpack how age, frailty, and comorbidities influence immunotherapy decisions — and what this means for everyday clinical practice. Start with Episode 175 - tinyurl.com/5xrdmshj Continue the conversation in Episode 176 - tinyurl.com/39daemnj 🔊 Available now wherever you get your podcasts. @nicolobattisti @majbaxter @RickyFrazer1 @AOlssonBrown @IOClinicalNet @immunobuddies @myESMO @ASCO @BOPACommittee @UKONSmember @UKAOSociety @oncodaily @OncoDailyIO @royalmarsdenNHS @NHSTayside @dundeeuni @JGeriOnc @YoungSIOG @siognah @onctrainees @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT #Immunotherapy #Frailty #Oncofrailty #CancerCare #OncologyPodcast #ClinicalPractice

🎄Merry Christmas from the IOCN! ✨ Thank you to our incredible immuno-oncology community for all you do. Wishing you a restful festive break! 🎅🎁

🎧 New Immunobuddies episode – Episode 173 Can low-dose PD-(L)1 immunotherapy expand access to life-saving cancer treatments? In this episode, Dr Pablo Jimenez (The Royal Marsden) discusses a systematic review exploring low-dose immune checkpoint inhibitor strategies, their clinical signals, cost implications, and what this could mean for global cancer care. 🔬 Evidence 🌍 Access & equity ⚖️ Benefits vs limitations Listen now 👉 buzzsprout.com/2128662/episod… #Immunobuddies #Immunotherapy #Oncology #IO #HealthEquity #CancerCare @PaulJiL @RickyFrazer1 @AOlssonBrown @IOClinicalNet @UKONSmember @UKAOSociety @BOPACommittee @myESMO @ASCO @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT @royalmarsdenNHS

What a busy day! We are all set for day 2 tomorrow! We go again! #ESMOImmuno25

The IOCN are at ESMO-IO this week! Come visit our stand to learn about our charity and what we do! We have lots of giveaways for you take home! #ESMOImmuno25 @RickyFrazer1 @AOlssonBrown @immunobuddies

🎙️ New Immunobuddies Episode! 🚨 We’re joined by international expert Professor Monty Pal from @CityofHope California for a deep dive into the clinical application of the microbiome in cancer immunotherapy. ❗️From CBM588 to toxicity, response, and future trials — this one is packed with insights. 🎧 Episode 171 is live now! open.spotify.com/episode/1QtMNq… #Immunobuddies #Oncology #Immunotherapy #Microbiome #KidneyCancer #Cancer #GutMicrobiome #OncologyPodcast @montypal @cityofhopeoc @RickyFrazer1 @AOlssonBrown @IOClinicalNet @UKONSmember @UKAOSociety @BOPACommittee @myESMO @ASCO @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT

🎙️ New Episode – Immunobuddies Podcast Episode 167: New Immunotherapies for Community Teams & Non-Oncologists (Part 1) With Dr Elise Lang, Macmillan GP Lead for Wales As immunotherapy becomes more common, what do community teams and non-oncologists really need to know? ✨ Key topics: ✅What immunotherapy is and how it differs from chemo 🔴Red flag side effects in primary care — even subtle ones like fatigue or dry mouth 🕐Late and long-term toxicities that can appear years after treatment 🔎How GPs can recognise, support and escalate concerns early 🎧 Perfect for GPs, nurses, pharmacists and anyone supporting cancer patients outside oncology. 👉 Listen now: tinyurl.com/3pdwywfj @DrEliseLang @RickyFrazer1 @AOlssonBrown @macmillancancer @VelindreTrust @VCC_EdAndDev @CardiffUniCPD @RCGPWales @UKONSmember @UKAOSociety @BOPACommittee @myESMO @ASCO @ONCOassist @OncoViews @VelindreCS @OncEd @OncologyNT #Immunobuddies #Immunotherapy #PrimaryCare #Macmillan #OncologyEducation #CommunityCare #IOCN #CancerCare

🧠 Reminder: IOCN UK-wide Survey – Access to Immunosuppressants for ICI Toxicities The IOCN and UKSACT Board have raised concerns with NHS England about serious inequalities in access to immunosuppressive treatments for immune checkpoint inhibitor (ICI) toxicities. Ahead of our national meeting with NHS England in November, we urgently need your input. 💬 Have your say: Share your experience of accessing biologics and JAK inhibitors for immune-related adverse events (irAEs) 🕒 Time to complete: ~10 minutes 📅 Deadline: Monday 10th November 2026 👉 Survey link: tinyurl.com/3xt3u6se Your responses will help shape national discussions and support the development of a standardised framework to ensure equitable access for all ICI patients. Let’s work together to reduce geographical disparities and improve outcomes for patients experiencing ICI-related toxicities. #IOCN #UKSACT #Immunotherapy #ImmunoOncology #ToxicityManagement #irAEs #Oncology #NHS #Immunosuppression @AOlssonBrown @RickyFrazer1 @brentocarrigan @Youngdr100 @will_oncology @TrudyGuinan @DTM_xx @UKONSmember @UKAOSociety @BOPACommittee @immunobuddies

🫵We need you to help shape our discussions with NHS England! 🗣️IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Ahead of a national meeting with NHS England in November, we’re asking the UK immunotherapy community to share their experiences via this important survey. Your input will help shape national discussions and support the development of a standardised framework to improve equitable access to biologics and JAK inhibitors for patients with immune-related adverse events (irAEs). 📷 Complete the survey here: tinyurl.com/3xt3u6se 📷 Deadline: Monday 10th November 2026 🤝Your voice matters! #UKSACT #Immunotherapy #Immunooncology #ToxicityManagement #irAEs #Oncology #NHS #Immunosuppression @AOlssonBrown @RickyFrazer1 @brentocarrigan @Youngdr100 @will_oncology @TrudyGuinan @DTM_xx @UKONSmember @UKAOSociety @BOPACommittee @immunobuddies

🎙️Final Episode of the Mini-Series is Out Now! Immunobuddies Podcast – Real-World Complex Case (Part 6) with Dr Jay Naik, Dr @RickyFrazer1 and Dr @AOlssonBrown We’re wrapping up this brilliant mini-series with a reflection episode — pulling together all the key learning points from Parts 1–5 of this real-world immunotherapy case. 💡 In this final episode, the team discusses: ✅ What they learned at each stage of the case ✅ Key decisions and how they changed as new information emerged ✅ Early recognition of irAEs and when to intervene ✅ The power of MDT problem-solving in complex scenarios ✅ What they’d do differently next time Short, practical, and full of real clinical insight — perfect for anyone working with immunotherapy patients. 🎧 Listen now: open.spotify.com/episode/0ZU1TL… #Immunobuddies #Immunotherapy #ImmunoOncology #irAEs #CancerCare #OncologyPodcast #ClinicalLearning @UKONSmember @UKAOSociety @BOPACommittee @OncEd @OncologyNT @myESMO @OncoViews